ARTICLE | Company News
GenVec licenses gene from NIH
February 22, 2000 8:00 AM UTC
GenVec (Gaithersburg, Md.) received exclusive rights to the pigment epithelium derived factor (PEDF) gene from NIH for use in treating blindness. The company said that PEDF is an antiangiogenic factor...